NCT04361396View on ClinicalTrials.gov

Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

June 16, 2020

Primary Completion Date

December 16, 2021

Study Completion Date

January 18, 2022

Conditions
Coronavirus Infection
Interventions
OTHER

Collection of samples

Only in enrolled patient : different samples will be taken at different times of the surgery (3 samples of pneumoperitoneum, 1 sample of peritoneal effusion or peritoneal lavage fluid and 1 sample of bile, in case of cholecystectomy.

Trial Locations (5)

93200

CH Delafontaine, Saint-Denis

94000

CH Intercommunal, Créteil

95107

CH Victor Dupouy, Argenteuil

95300

Department of General and Digestive Surgery, Hospital René Dubos, Pontoise

Department of Gynecology-Obstetrics, Hospital René Dubos, Pontoise

All Listed Sponsors
lead

Hôpital NOVO

OTHER

NCT04361396 - Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients | Biotech Hunter | Biotech Hunter